Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 3, 2016, Pages 261-267

  Merino, J ^a,b   Sala Vila, A ^c,d   Plana, N ^a,b   Girona, J ^a,b   Vallve, J C ^a,b   Ibarretxe, D ^a,b   Ros, E ^c,d   Ferre R ^a,b   Heras, M ^a,b   Masana, L ^a,b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

Cardiovascular risk; Lipogenesis; Lipokine; Metabolic syndrome; Palmitoleate

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; FATTY ACID BINDING PROTEIN 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PALMITOLEIC ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; ADIPONECTIN; C REACTIVE PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; FABP4 PROTEIN, HUMAN; FATTY ACID; FATTY ACID BINDING PROTEIN; INSULIN; MONOUNSATURATED FATTY ACID; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ABDOMINAL FAT; ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTICLE; ASSESSMENT OF HUMANS; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG USE; DYSLIPIDEMIA; ECHOGRAPHY; FATTY LIVER INDEX; FEMALE; GAS CHROMATOGRAPHY; GENDER; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOLIPEMIA; LIPOGENESIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SMOKING; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; BLOOD; BODY MASS; METABOLISM; PHYSIOLOGY; PREVALENCE; RISK FACTOR;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL ESTER TRANSFER PROTEINS; CROSS-SECTIONAL STUDIES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; LIPOGENESIS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PREVALENCE; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84959464589     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.12.008     Document Type: Article

References (24)

1. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008, 47:348-380.
2. Hodson L., Karpe F. Is there something special about palmitoleate?. Curr Opin Clin Nutr Metab Care 2013, 2:225-231.
3. Pinnick K.E., Neville M.J., Fielding B.A., Frayn K.N., Karpe F., Hodson L. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes 2012, 6:1399-1403.
4. Cao H., Gerhold K., Mayers J.R., Wiest M.M., Watkins S.M., Hotamisligil G.S. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 6:933-944.
5. Stefan N.K., Kantartzis N., Celebi H., Staiger H., Machann J., Schick F., et al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 2010, 33:405-407.
6. Fabbrini E., Magkos F., Su X., Abumrad N.A., Nejedly N., Coughlin C.C., et al. Insulin sensitivity is not associated with palmitoleate availability in obese humans. J Lipid Res 2011, 52:808-812.
7. Bergman B.C., Howard D., Schauer I.E., Maahs D.M., Snell-Bergeon J.K., Eckel R.H., et al. The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab 2013, 1:40-50.
8. Puri P., Wiest M.M., Cheung O., Mirshahi F., Sargeant C., Min H.K., et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009, 50:1827-1838.
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in Adults (Adult treatment panel III). Third report of the National cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
10. Burdge G.C., Wright P., Jones A.E., Wootton S.A. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 2000, 84:781-787.
11. Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23:75-80.
12. Adji A., O'Rourke M.F., Namasivayam M. Arterial stiffness, its assessment, prognostic value, and implications for treatment. Am J Hypertens 2011, 24:5-17.
13. Suzuki R., Watanabe S., Hirai Y., Akiyama K., Nishide T., Matsushima Y., et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 1993, 95:309-314.
14. Bedogni G., Bellentani S., Miglioli L., Masutti F., Passalacqua M., Castiglione A., et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33-36.
15. Asciutti-Moura L.S., Guilland J.C., Fuchs F., Richard D., Klepping J. Fatty acid composition of serum lipids and its relation to diet in an elderly institutionalized population. Am J Clin Nutr 1988, 48:980-987.
16. Lopes S.M., Trimbo S.L., Mascioli E.A., Blackburn G.L. Human plasma fatty acid variations and how they are related to dietary intake. Am J Clin Nutr 1991, 53:628-637.
17. Gong J., Campos H., McGarvey S., Wu Z., Goldberg R., Baylin A. Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine?. Am J Clin Nutr 2011, 1:186-191.
18. Garaulet M., Hernandez-Morante J.J., Tebar F.J., Zamora S. Relation between degree of obesity and site-specific adipose tissue fatty acid composition in a Mediterranean population. Nutrition 2011, 2:170-176.
19. Aranceta J., Perez-Rodrigo C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. Br J Nutr 2012, 107:S8-S22.
20. Carvalhana S., Leitao J., Alves A.C., Bourbon M., Cortez-Pinto H. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound. Liver Int 2014, 6:111-117.
21. Cuthbertson D.J., Weicket M.O., Lythgoe D., Sprung V.S., Dobson R., Shoajee-Moradie F., et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-rersistant individuals. Eur J Endocrinol 2014, 5:561-569.
22. Koehler E.M., Schouten J.N., Hansen B.E., Hofman A., Stricker B.H., Janssen H.L. External validation of the fatty liver index for identifying non-alcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol 2013, 9:1201-1204.
23. Jiang Z.Y., Xu C.Y., Chang X.X., Li W.W., Sun L.Y., Yang X.B., et al. Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients. BMC Gastroenterol 2013, 8:110-113.
24. Pollak J.F., Pencina M.J., Pencina K.M., O'Donnell C.J., Wolf P.A., D'Agostino R.B. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011, 3:213-221.